High-dose therapy in breast cancer

Out of favor but not out of promise

S. Glück, D. Stewart

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The evidence for use of high-dose chemotherapy and autologous stem cell transplantation for breast cancer still remains inconclusive at best. A number of prospective randomized phase III studies have been either published or presented recently or are underway in North America and Europe. It will be crucial to complete the available prospective randomized phase III study and obtain the data when all studies reach a mature status. Only then will level I evidence become available to determine the efficacy and effectiveness of high-dose chemotherapy and autologous stem cell transplantation in breast cancer.

Original languageEnglish
Pages (from-to)1017-1019
Number of pages3
JournalBone Marrow Transplantation
Volume25
Issue number10
StatePublished - May 30 2000
Externally publishedYes

Fingerprint

Stem Cell Transplantation
Breast Neoplasms
Drug Therapy
North America
Therapeutics

Keywords

  • Breast cancer
  • Controversy
  • Evidence for efficacy
  • High-dose chemotherapy

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

High-dose therapy in breast cancer : Out of favor but not out of promise. / Glück, S.; Stewart, D.

In: Bone Marrow Transplantation, Vol. 25, No. 10, 30.05.2000, p. 1017-1019.

Research output: Contribution to journalArticle

Glück, S & Stewart, D 2000, 'High-dose therapy in breast cancer: Out of favor but not out of promise', Bone Marrow Transplantation, vol. 25, no. 10, pp. 1017-1019.
Glück, S. ; Stewart, D. / High-dose therapy in breast cancer : Out of favor but not out of promise. In: Bone Marrow Transplantation. 2000 ; Vol. 25, No. 10. pp. 1017-1019.
@article{60f3c633bafd4f0296d66236de8993ea,
title = "High-dose therapy in breast cancer: Out of favor but not out of promise",
abstract = "The evidence for use of high-dose chemotherapy and autologous stem cell transplantation for breast cancer still remains inconclusive at best. A number of prospective randomized phase III studies have been either published or presented recently or are underway in North America and Europe. It will be crucial to complete the available prospective randomized phase III study and obtain the data when all studies reach a mature status. Only then will level I evidence become available to determine the efficacy and effectiveness of high-dose chemotherapy and autologous stem cell transplantation in breast cancer.",
keywords = "Breast cancer, Controversy, Evidence for efficacy, High-dose chemotherapy",
author = "S. Gl{\"u}ck and D. Stewart",
year = "2000",
month = "5",
day = "30",
language = "English",
volume = "25",
pages = "1017--1019",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - High-dose therapy in breast cancer

T2 - Out of favor but not out of promise

AU - Glück, S.

AU - Stewart, D.

PY - 2000/5/30

Y1 - 2000/5/30

N2 - The evidence for use of high-dose chemotherapy and autologous stem cell transplantation for breast cancer still remains inconclusive at best. A number of prospective randomized phase III studies have been either published or presented recently or are underway in North America and Europe. It will be crucial to complete the available prospective randomized phase III study and obtain the data when all studies reach a mature status. Only then will level I evidence become available to determine the efficacy and effectiveness of high-dose chemotherapy and autologous stem cell transplantation in breast cancer.

AB - The evidence for use of high-dose chemotherapy and autologous stem cell transplantation for breast cancer still remains inconclusive at best. A number of prospective randomized phase III studies have been either published or presented recently or are underway in North America and Europe. It will be crucial to complete the available prospective randomized phase III study and obtain the data when all studies reach a mature status. Only then will level I evidence become available to determine the efficacy and effectiveness of high-dose chemotherapy and autologous stem cell transplantation in breast cancer.

KW - Breast cancer

KW - Controversy

KW - Evidence for efficacy

KW - High-dose chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=0034029496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034029496&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 1017

EP - 1019

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 10

ER -